Hepatitis A: clinical manifestations and management.
Jeong SH, Lee HS.
Intervirology. 2010;53(1):15-9. doi: 10.1159/000252779. Epub 2010 Jan 5.
Cholestasis.
Popper H.
Annu Rev Med. 1968;19:39-56. doi: 10.1146/annurev.me.19.020168.000351.
Prolonged cholestasis after acute viral hepatitis: successfully treated with oral steroid.
Jayappa M, Kumar P, Goyal JP.
BMJ Case Rep. 2020 May 21;13(5):e234430. doi: 10.1136/bcr-2020-234430.
Successful treatment of prolonged cholestasis following hepatitis A infection in a child with oral steroid therapy.
Chirag R, Arun Babu T.
BMJ Case Rep. 2023 Dec 9;16(12):e257477. doi: 10.1136/bcr-2023-257477.
Hepatitis.
Russell RI.
Scott Med J. 1970 Sep;15(9):331-8. doi: 10.1177/003693307001500905.
Atypical manifestations of hepatitis A virus infection.
Muñoz-Martínez SG, Díaz-Hernández HA, Suárez-Flores D, Sánchez-Ávila JF, Gamboa-Domínguez A, García-Juárez I, Torre A.
Rev Gastroenterol Mex (Engl Ed). 2018 Apr-Jun;83(2):134-143. doi: 10.1016/j.rgmx.2017.10.004. Epub 2018 Apr 21.
HEPATITIS A. THE FEATURES OF DISEASE COURSE IN ADULTS.
Pryimenko N, Koval T, Kotelevska T, Bodnar V, Syzova L, Marchenko O.
Wiad Lek. 2023;76(12):2572-2578. doi: 10.36740/WLek202312104.
Atypical clinical manifestations of hepatitis A.
Schiff ER.
Vaccine. 1992;10 Suppl 1:S18-20. doi: 10.1016/0264-410x(92)90534-q.
Metabolic differences between hepatitis and cholestasis in human liver.
Scherstén T.
Prog Liver Dis. 1972;4:133-50.
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection.
Coppola N, Genovese D, Pisaturo M, Taffon S, Argentini C, Pasquale G, Sagnelli C, Piccinino F, Rapicetta M, Sagnelli E.
Clin Infect Dis. 2007 May 1;44(9):e73-7. doi: 10.1086/513430. Epub 2007 Mar 28.
